Photo - DermoTech GmbH
play_arrow
View
54337

DermoTech GmbH

Germany
Market: Mechanical engineering, Medicine
Stage of the project: Prototype or product is ready

Date of last change: 03.10.2021
Show contacts
0
equalizer from 2000
help
Calculated and estimated occupancy of the project (more about ratings)
My rating
1
2
3
4
5
6
7
8
9
10
Average rating:
 

Idea

The first causal therapy for atopic dermatitis (Neurodermitis), 6% prevalence. Medically superior over all alternatives, therapy result remains stable. Inexpensive treatment with high social impact.

Current Status

2000 patients have been treated so far with the legacy devices. All of the dermatologists who were operating the devices are supporting the innovation. We are developing a new generation of devices actually, and we need a large study to enable insurance refunding of treatment costs.

Problem or Opportunity

Atopic dermatitis (Neurodermitis) cannot be cured with pharmaceuticals. Patients need medication for their remaining lifetime. If they stop medication, there will be a relapse. Newest pharmaceuticals are very expensive which is a burden for public health systems. There is little long-time experience with such pharmaceuticals. Another option is UV irradiation, having carcinogenic side effects and should not be used for children. Children and teenagers often suffer from atopic dermatitis.

Solution (product or service)

Blue Light irradiation, free of UV, is a new discovery to have an anti-inflammatory effect. Irradiation with DermoTech devices is the first causal therapy and patients do not need further treatment once therapy is achieved.

Business model

Research & development and manufacturing of blue light irradiation devices for therapy of human diseases caused by the immune system, bacteria, fungi or viruses.
5,00
1
2
3
4
5
1 voice
Sign in/Sign up
arrow_back
EN
more_horiz
close
visibility4
star0
Add to favorites
Delete from favorites
share
close
thumb_up0
Like
Unlike
Idea
Current Status
Market
Problem or Opportunity
Solution (product or service)
Competitors
Advantages or differentiators
Finance
Invested in previous rounds, $
Business model
Money will be spent on
Offer for investor
Team or Management
Mentors & Advisors
Lead investor
Risks
Incubation/Acceleration programs accomplishment
Won the competition and other awards
Invention/Patent
Photos
Product Video